Be aware of your markets

Latest news

Archive
News

May 17, 2024

SPARK Finland, SPARK at Stanford, Stanford University, SPARK Norway, Nordic SPARK programs, UCSF, Berkeley, SDDS 2024

Nordic SPARK programs had a great tour in Silicon Valley

Nordic SPARK programs have had years of successful collaboration in boosting the emergence of new value-creating solutions in the health tech and life science fields. Once again, we were on…

News

Mar 22, 2024

SPARK Finland, SPARK Norway, Nordic SPARK programs, UCSF, Silicon Valley Tour, Stanford Drug Discovery Symposium 2024, SDDS, Stanford, Berkeley

Nordic SPARK programs heading to the Silicon Valley tour

Nordic SPARK programs have had years of successful collaboration in boosting the emergence of new value-creating solutions in the health tech and life science fields. It has resulted in multiple…

News

Feb 12, 2024

SPARK Finland started a new four-year period

In December 2023, the SPARK Finland consortium signed a four-year program agreement for years 2024-2027. This is a continuation of the journey that started officially in spring 2017. SPARK Finland has…

News

May 30, 2023

SPARK Finland, SPARK Norway, SPARK Denmark, European SPARK network, Nordic SPARK programs

Nordic SPARK programs deepening collaboration

Nordic SPARK programs are deepening collaboration in developing program offering. Last week, program directors of SPARK Finland, SPARK Norway and SPARK Denmark were designing next steps for their collaborative activities.…

News

Apr 19, 2023

SPARK Finland, Stanford University, SPARK Norway, SPARK Denmark, Nordic SPARK programs, Silicon Valley, Stanford Drug Discovery Symposium 2023, UCSF

Nordic SPARK programs on Silicon Valley tour

Nordic SPARK programs have had years of successful collaboration in boosting emergence of new cool solutions in health tech and life science field. Collaboration in mentoring of the projects started…

News

Mar 31, 2023

SPARKee, SPARK Finland, Sartar Therapeutics, DecoDerma, Orphan drug designation, FDA, EMA, alumni

Decoderma and Sartar received orphan-drug designations

Finnish SPARKee Decoderma and alumni Sartar Therapeutics have announced recently fantastic news regarding their progress in drug development process. Orphan drug status is assigned to a medicine intended for use…

News

Nov 18, 2022

SPARK Finland, Amanda Paananen, Management Team, Anu Meerwaldt

Anu Meerwaldt joined SPARK management team

We are truly thrilled to announce that Anu Meerwaldt has joined SPARK Finland management team. Amanda Paananen, Development Manager of Helsinki capital region, is now on her leave and will…

News

Nov 3, 2022

SPARK Finland, Koite Health, Lumoral, Open call, Tommi Pätilä, co-founder, SpectroCor

Call for new SPARK projects is OPEN

Call for SPARK Finland program is once again open. Twice a year – in May/June and Nov/Dec – an expert panel of faculty and industry advisors reviews proposals submitted from…

News

Oct 19, 2022

DecoDerma, Tero Järvinen, Albert Lasker Medical Research Award, Orphan drug designation, Erkki Ruoslahti

Key advisor of DecoDerma awarded by Albert Lasker Prize

Dr. Erkki Ruoslahti (MD, PhD), the chairman of the advisory board for the Finnish SPARK project DecoDerma, is one of three winners of the Albert Lasker Medical Research Award in…

News

Oct 11, 2022

SPARK Finland, Voima Ventures, NADMED, Financing round

Voima Ventures to back NADMED

The easy and reliable method that measures all NAD metabolites has also convinced financiers. SPARK Finland alumni NADMED recently completed its first financing round of half a million euros, led…